BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davidson S, Maini MK, Wack A. Disease-promoting effects of type I interferons in viral, bacterial, and coinfections. J Interferon Cytokine Res. 2015;35:252-264. [PMID: 25714109 DOI: 10.1089/jir.2014.0227] [Cited by in Crossref: 103] [Cited by in F6Publishing: 95] [Article Influence: 17.2] [Reference Citation Analysis]
Number Citing Articles
1 Nistal-Villán E, Argemi J, de Jaime-Soguero A, Ferrero R, di Scala M, Rodriguez-Garcia E, Coll A, Rius-Rocabert S, Prieto J, González-Aseguinolaza G, Aragón T. Linking the Expression of Therapeutic Genes to Unfolded Protein Response: A New Option for Anti-Hepatitis B Virus Gene Therapy. Hum Gene Ther 2021;32:341-8. [PMID: 33213214 DOI: 10.1089/hum.2019.336] [Reference Citation Analysis]
2 Yip TF, Selim ASM, Lian I, Lee SM. Advancements in Host-Based Interventions for Influenza Treatment. Front Immunol 2018;9:1547. [PMID: 30042762 DOI: 10.3389/fimmu.2018.01547] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
3 Zhang Y, Chen Y, Meng Z. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.Front Immunol. 2020;11:577442. [PMID: 33240265 DOI: 10.3389/fimmu.2020.577442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Ahmad T, Chaudhuri R, Joshi MC, Almatroudi A, Rahmani AH, Ali SM. COVID-19: The Emerging Immunopathological Determinants for Recovery or Death. Front Microbiol 2020;11:588409. [PMID: 33335518 DOI: 10.3389/fmicb.2020.588409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Weidmann MD, Ofori K, Rai AJ. Laboratory Biomarkers in the Management of Patients With COVID-19. Am J Clin Pathol 2021;155:333-42. [PMID: 33107558 DOI: 10.1093/ajcp/aqaa205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Peteranderl C, Herold S. The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond. Front Immunol 2017;8:313. [PMID: 28382038 DOI: 10.3389/fimmu.2017.00313] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
7 Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, Drosten C, Weber F. Inhibition of SARS-CoV-2 by type I and type III interferons. J Biol Chem 2020;295:13958-64. [PMID: 32587093 DOI: 10.1074/jbc.AC120.013788] [Cited by in Crossref: 84] [Cited by in F6Publishing: 42] [Article Influence: 84.0] [Reference Citation Analysis]
8 Gémez-Mata J, Labella AM, Bandín I, Borrego JJ, García-Rosado E. Immunogene expression analysis in betanodavirus infected-Senegalese sole using an OpenArray® platform. Gene 2021;774:145430. [PMID: 33444680 DOI: 10.1016/j.gene.2021.145430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, Dy M, Scott-Algara D, Manoury B, Zirafi O, McCort-Tranchepain I, Durroux T, Bachelerie F, Schwartz O, Münch J, Wack A, Nisole S, Herbeuval JP. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun 2017;8:14253. [PMID: 28181493 DOI: 10.1038/ncomms14253] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
10 Rodrigues KB, Dufort MJ, Llibre A, Speake C, Rahman MJ, Bondet V, Quiel J, Linsley PS, Greenbaum CJ, Duffy D, Tarbell KV. Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes. Diabetologia 2020;63:1576-87. [PMID: 32500289 DOI: 10.1007/s00125-020-05179-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
11 Marazzi I, Greenbaum BD, Low DHP, Guccione E. Chromatin dependencies in cancer and inflammation. Nat Rev Mol Cell Biol 2018;19:245-61. [DOI: 10.1038/nrm.2017.113] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
12 Froggatt HM, Harding AT, Chaparian RR, Heaton NS. ETV7 limits antiviral gene expression and control of influenza viruses. Sci Signal 2021;14:eabe1194. [PMID: 34257104 DOI: 10.1126/scisignal.abe1194] [Reference Citation Analysis]
13 Wong RR, Abd-Aziz N, Affendi S, Poh CL. Role of microRNAs in antiviral responses to dengue infection. J Biomed Sci 2020;27:4. [PMID: 31898495 DOI: 10.1186/s12929-019-0614-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 23.0] [Reference Citation Analysis]
14 Talarico LB, Byrne AB, Amarilla S, Lovera D, Vázquez C, Chamorro G, Acosta PL, Ferretti A, Caballero MT, Arbo A, Polack FP. Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay. J Clin Virol 2017;97:10-7. [PMID: 29078078 DOI: 10.1016/j.jcv.2017.10.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
15 Serrano-Castro PJ, Estivill-Torrús G, Cabezudo-García P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, Suárez-Pérez J, Jiménez-Hernández MD, Moya-Molina MÁ, Oliver-Martos B, Arrabal-Gómez C, Rodríguez de Fonseca F. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurologia (Engl Ed) 2020;35:245-51. [PMID: 32364119 DOI: 10.1016/j.nrl.2020.04.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 45.0] [Reference Citation Analysis]
16 Pronin AV, Narovlyansky AN, Shulzhenko AE, Sanin AV, Sedov AM. New polyprenyl phosphate based preparation Fortepren(®) as promising cytokine regulationg antiviral remedy. Cytokine Growth Factor Rev 2016;30:119-26. [PMID: 27235090 DOI: 10.1016/j.cytogfr.2016.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Clement M, Marsden M, Stacey MA, Abdul-Karim J, Gimeno Brias S, Costa Bento D, Scurr MJ, Ghazal P, Weaver CT, Carlesso G, Clare S, Jones SA, Godkin A, Jones GW, Humphreys IR. Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence. PLoS Pathog 2016;12:e1006050. [PMID: 27926930 DOI: 10.1371/journal.ppat.1006050] [Cited by in F6Publishing: 31] [Reference Citation Analysis]
18 Patidar GK, Land KJ, Vrielink H, Rahimi-Levene N, Dann EJ, Al-Humaidan H, Spitalnik SL, Dhiman Y, So-Osman C, Hindawi SI. Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices. Vox Sang 2021;116:798-807. [PMID: 33730761 DOI: 10.1111/vox.13067] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Serrano-castro P, Estivill-torrús G, Cabezudo-garcía P, Reyes-bueno J, Ciano Petersen N, Aguilar-castillo M, Suárez-pérez J, Jiménez-hernández M, Moya-molina M, Oliver-martos B, Arrabal-gómez C, Rodríguez de Fonseca F. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? Neurología (English Edition) 2020;35:245-51. [DOI: 10.1016/j.nrleng.2020.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 25.0] [Reference Citation Analysis]
20 Stawowczyk M, Naseem S, Montoya V, Baker DP, Konopka J, Reich NC. Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicans Infection. mBio 2018;9:e00365-18. [PMID: 29666281 DOI: 10.1128/mBio.00365-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Biondo C, Lentini G, Beninati C, Teti G. The dual role of innate immunity during influenza. Biomed J 2019;42:8-18. [PMID: 30987709 DOI: 10.1016/j.bj.2018.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
22 Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, Makvandi P. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside. ACS Biomater Sci Eng 2021;7:2150-76. [PMID: 33979143 DOI: 10.1021/acsbiomaterials.1c00318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Moreno P, Gemez-Mata J, Garcia-Rosado E, Bejar J, Labella AM, Souto S, Alonso MC. Differential immunogene expression profile of European sea bass (Dicentrarchus labrax, L.) in response to highly and low virulent NNV. Fish Shellfish Immunol 2020;106:56-70. [PMID: 32702480 DOI: 10.1016/j.fsi.2020.06.052] [Reference Citation Analysis]
24 Alarcon PC, Damen MSMA, Madan R, Deepe GS Jr, Spearman P, Way SS, Divanovic S. Adipocyte inflammation and pathogenesis of viral pneumonias: an overlooked contribution. Mucosal Immunol 2021. [PMID: 33958704 DOI: 10.1038/s41385-021-00404-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA, Jeda AS, Dashtbin S, Jalalifar S, Mohammadzadeh R, Teimoori A, Tari K, Salari M, Ghiasvand S, Kazemi S, Yousefimashouf R, Keyvani H, Karampoor S. Bacterial co-infections with SARS-CoV-2. IUBMB Life 2020;72:2097-111. [PMID: 32770825 DOI: 10.1002/iub.2356] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 38.0] [Reference Citation Analysis]
26 Ho J, Pelzel C, Begitt A, Mee M, Elsheikha HM, Scott DJ, Vinkemeier U. STAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling Pathways. PLoS Biol 2016;14:e2000117. [PMID: 27780205 DOI: 10.1371/journal.pbio.2000117] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
27 Keam S, Megawati D, Patel SK, Tiwari R, Dhama K, Harapan H. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection. Rev Med Virol 2020;30:e2123. [PMID: 32648313 DOI: 10.1002/rmv.2123] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 40.0] [Reference Citation Analysis]
28 Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther 2021;:1-17. [PMID: 33832398 DOI: 10.1080/14787210.2021.1915129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
29 Gudkov AV, Komarova EA. p53 and the Carcinogenicity of Chronic Inflammation. Cold Spring Harb Perspect Med 2016;6:a026161. [PMID: 27549311 DOI: 10.1101/cshperspect.a026161] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
30 Liu BC, Sarhan J, Poltorak A. Host-Intrinsic Interferon Status in Infection and Immunity. Trends Mol Med 2018;24:658-68. [PMID: 30060835 DOI: 10.1016/j.molmed.2018.06.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
31 Davidson S, McCabe TM, Crotta S, Gad HH, Hessel EM, Beinke S, Hartmann R, Wack A. IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment. EMBO Mol Med 2016;8:1099-112. [PMID: 27520969 DOI: 10.15252/emmm.201606413] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 24.8] [Reference Citation Analysis]
32 Feng M, Dai M, Cao W, Tan Y, Li Z, Shi M, Zhang X. ALV-J strain SCAU-HN06 induces innate immune responses in chicken primary monocyte-derived macrophages. Poult Sci 2017;96:42-50. [PMID: 27486255 DOI: 10.3382/ps/pew229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
33 Ardanuy J, Scanlon K, Skerry C, Fuchs SY, Carbonetti NH. Age-Dependent Effects of Type I and Type III IFNs in the Pathogenesis of Bordetella pertussis Infection and Disease. J Immunol 2020;204:2192-202. [PMID: 32152071 DOI: 10.4049/jimmunol.1900912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Siqueira IR, Palazzo RP, Cechinel LR. Circulating extracellular vesicles delivering beneficial cargo as key players in exercise effects. Free Radic Biol Med 2021;172:273-85. [PMID: 34119583 DOI: 10.1016/j.freeradbiomed.2021.06.007] [Reference Citation Analysis]
35 Szymona K, Zdzisińska B, Karakuła-juchnowicz H, Kocki T, Kandefer-szerszeń M, Flis M, Rosa W, Urbańska EM. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia. Neurotox Res 2017;32:17-26. [DOI: 10.1007/s12640-017-9714-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
36 Song TZ, Zheng HY, Han JB, Jin L, Yang X, Liu FL, Luo RH, Tian RR, Cai HR, Feng XL, Liu C, Li MH, Zheng YT. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques. Zool Res 2020;41:503-16. [PMID: 32772513 DOI: 10.24272/j.issn.2095-8137.2020.202] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
37 Fox LE, Locke MC, Lenschow DJ. Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease. Front Immunol 2020;11:606874. [PMID: 33408718 DOI: 10.3389/fimmu.2020.606874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect. 2020;80:607-613. [PMID: 32283152 DOI: 10.1016/j.jinf.2020.03.037] [Cited by in Crossref: 1000] [Cited by in F6Publishing: 876] [Article Influence: 1000.0] [Reference Citation Analysis]
39 Midha IK, Kumar N, Kumar A, Madan T. Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings. Rev Med Virol 2021;31:1-14. [PMID: 33382930 DOI: 10.1002/rmv.2204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Bardina SV, Brown JA, Michlmayr D, Hoffman KW, Sum J, Pletnev AG, Lira SA, Lim JK. Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis. J Virol 2017;91:e02409-16. [PMID: 28356527 DOI: 10.1128/JVI.02409-16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
41 Wu W, Metcalf JP. The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains? J Innate Immun 2020;12:437-47. [PMID: 32564033 DOI: 10.1159/000508379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
42 Kuriakose T, Zheng M, Neale G, Kanneganti TD. IRF1 Is a Transcriptional Regulator of ZBP1 Promoting NLRP3 Inflammasome Activation and Cell Death during Influenza Virus Infection. J Immunol 2018;200:1489-95. [PMID: 29321274 DOI: 10.4049/jimmunol.1701538] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
43 Li P, Lu Z, Li Q, Wang Z, Guo Y, Cai C, Wang S, Liu P, Su X, Huang Y, Dong Y, Qiu W, Ling Y, Yarmus L, Luo F, Zeng L, Bai C, Zhang W. Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6. Front Mol Biosci 2021;8:651662. [PMID: 33937333 DOI: 10.3389/fmolb.2021.651662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Tomer S, Chawla YK, Duseja A, Arora SK. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection. World J Gastroenterol 2016;22:5173-82. [PMID: 27298560 DOI: 10.3748/wjg.v22.i22.5173] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Moreira-Teixeira L, Mayer-Barber K, Sher A, O'Garra A. Type I interferons in tuberculosis: Foe and occasionally friend. J Exp Med 2018;215:1273-85. [PMID: 29666166 DOI: 10.1084/jem.20180325] [Cited by in Crossref: 96] [Cited by in F6Publishing: 75] [Article Influence: 32.0] [Reference Citation Analysis]
46 Reich NC. Too much of a good thing: Detrimental effects of interferon. Semin Immunol 2019;43:101282. [PMID: 31771763 DOI: 10.1016/j.smim.2019.101282] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
47 Cook LE, Locke MC, Young AR, Monte K, Hedberg ML, Shimak RM, Sheehan KCF, Veis DJ, Diamond MS, Lenschow DJ. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation. J Virol 2019;94:e00841-19. [PMID: 31619554 DOI: 10.1128/JVI.00841-19] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
48 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
49 Manna S, Baindara P, Mandal SM. Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2. J Infect Public Health 2020;13:1397-404. [PMID: 32712106 DOI: 10.1016/j.jiph.2020.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
50 Lulli D, Carbone ML, Pastore S. Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin. Oncotarget 2016;7:47777-93. [PMID: 27322144 DOI: 10.18632/oncotarget.10013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
51 Bakaletz LO. Viral-bacterial co-infections in the respiratory tract. Curr Opin Microbiol 2017;35:30-5. [PMID: 27940028 DOI: 10.1016/j.mib.2016.11.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
52 Zhang H, Zheng H, Zhu J, Dong Q, Wang J, Fan H, Chen Y, Zhang X, Han X, Li Q, Lu J, Tong Y, Chen Z. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis. J Proteome Res 2021;20:2224-39. [PMID: 33666082 DOI: 10.1021/acs.jproteome.0c00758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
53 Jafarzadeh A, Nemati M, Saha B, Bansode YD, Jafarzadeh S. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons. Viral Immunol 2021;34:307-20. [PMID: 33147113 DOI: 10.1089/vim.2020.0076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
54 Travar M, Petkovic M, Verhaz A. Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection. Arch Immunol Ther Exp (Warsz) 2016;64:19-31. [PMID: 26362801 DOI: 10.1007/s00005-015-0365-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
55 Maini MK, Pallett LJ. Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand. Lancet Gastroenterol Hepatol 2018;3:192-202. [PMID: 29870733 DOI: 10.1016/S2468-1253(18)30007-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 12.3] [Reference Citation Analysis]
56 Oosenbrug T, van de Graaff MJ, Haks MC, van Kasteren S, Ressing ME. An alternative model for type I interferon induction downstream of human TLR2. J Biol Chem 2020;295:14325-42. [PMID: 32796029 DOI: 10.1074/jbc.RA120.015283] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Choi JY, Kim SH, Jung I, Shin EC. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5. [PMID: 32651212 DOI: 10.1126/sciimmunol.abd1554] [Cited by in Crossref: 255] [Cited by in F6Publishing: 190] [Article Influence: 255.0] [Reference Citation Analysis]
58 McKellar J, Rebendenne A, Wencker M, Moncorgé O, Goujon C. Mammalian and Avian Host Cell Influenza A Restriction Factors. Viruses 2021;13:522. [PMID: 33810083 DOI: 10.3390/v13030522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Dulek DE, Fuhlbrigge RC, Tribble AC, Connelly JA, Loi MM, El Chebib H, Chandrakasan S, Otto WR, Diorio C, Keim G, Walkovich K, Jaggi P, Girotto JE, Yarbrough A, Behrens EM, Cron RQ, Bassiri H. Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients. J Pediatric Infect Dis Soc 2020;9:716-37. [PMID: 32808988 DOI: 10.1093/jpids/piaa098] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
60 Zhou BX, Li J, Liang XL, Pan XP, Hao YB, Xie PF, Jiang HM, Yang ZF, Zhong NS. β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling. Acta Pharmacol Sin 2020;41:1178-96. [PMID: 32504068 DOI: 10.1038/s41401-020-0403-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
61 Nguyen TA, Smith BRC, Tate MD, Belz GT, Barrios MH, Elgass KD, Weisman AS, Baker PJ, Preston SP, Whitehead L, Garnham A, Lundie RJ, Smyth GK, Pellegrini M, O'Keeffe M, Wicks IP, Masters SL, Hunter CP, Pang KC. SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune Recognition. Immunity 2017;47:498-509.e6. [PMID: 28916264 DOI: 10.1016/j.immuni.2017.08.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 13.8] [Reference Citation Analysis]
62 Maini MK, Burton AR. Restoring, releasing or replacing adaptive immunity in chronic hepatitis B. Nat Rev Gastroenterol Hepatol. 2019;16:662-675. [PMID: 31548710 DOI: 10.1038/s41575-019-0196-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 16.5] [Reference Citation Analysis]
63 Ayesha B, Kumthekar A, Jain R, Patel S, Ramesh M, Ferastraoaru DE, Hudes G, Karagic M, Zafar S, Bartash R, Vasquez-Canizares N, Kitsis E, Tagoe C, Wahezi DM, Rubinstein T, Broder A. Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force. ACR Open Rheumatol 2021;3:133-7. [PMID: 33547873 DOI: 10.1002/acr2.11220] [Reference Citation Analysis]
64 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
65 Wack A, Terczyńska-Dyla E, Hartmann R. Guarding the frontiers: the biology of type III interferons. Nat Immunol 2015;16:802-9. [PMID: 26194286 DOI: 10.1038/ni.3212] [Cited by in Crossref: 182] [Cited by in F6Publishing: 169] [Article Influence: 30.3] [Reference Citation Analysis]
66 Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529-539. [PMID: 28466096 DOI: 10.1007/s00281-017-0629-x] [Cited by in Crossref: 1170] [Cited by in F6Publishing: 1029] [Article Influence: 292.5] [Reference Citation Analysis]
67 Sheth AR, Grewal US, Patel HP, Thakkar S, Garikipati S, Gaddam J, Bawa D. Possible mechanisms responsible for acute coronary events in COVID-19. Med Hypotheses 2020;143:110125. [PMID: 32763657 DOI: 10.1016/j.mehy.2020.110125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
68 Shaabani N, Honke N, Nguyen N, Huang Z, Arimoto KI, Lazar D, Loe TK, Lang KS, Prinz M, Knobeloch KP, Zhang DE, Teijaro JR. The probacterial effect of type I interferon signaling requires its own negative regulator USP18. Sci Immunol 2018;3:eaau2125. [PMID: 30266866 DOI: 10.1126/sciimmunol.aau2125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
69 Rebello CJ, Kirwan JP, Greenway FL. Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? Int J Obes (Lond) 2020;44:1810-7. [PMID: 32647360 DOI: 10.1038/s41366-020-0640-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 29.0] [Reference Citation Analysis]
70 Fouladseresht H, Doroudchi M, Rokhtabnak N, Abdolrahimzadehfard H, Roudgari A, Sabetian G, Paydar S. Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19. Cytokine Growth Factor Rev 2021;58:32-48. [PMID: 33199179 DOI: 10.1016/j.cytogfr.2020.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
71 Prokunina-Olsson L, Alphonse N, Dickenson RE, Durbin JE, Glenn JS, Hartmann R, Kotenko SV, Lazear HM, O'Brien TR, Odendall C, Onabajo OO, Piontkivska H, Santer DM, Reich NC, Wack A, Zanoni I. COVID-19 and emerging viral infections: The case for interferon lambda. J Exp Med 2020;217:e20200653. [PMID: 32289152 DOI: 10.1084/jem.20200653] [Cited by in Crossref: 104] [Cited by in F6Publishing: 86] [Article Influence: 104.0] [Reference Citation Analysis]
72 Zanotti C, Razzuoli E, Crooke H, Soule O, Pezzoni G, Ferraris M, Ferrari A, Amadori M. Differential Biological Activities of Swine Interferon-α Subtypes. J Interferon Cytokine Res 2015;35:990-1002. [PMID: 26447602 DOI: 10.1089/jir.2015.0076] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
73 Huang X, Liu X, Meyers K, Liu L, Su B, Wang P, Li Z, Li L, Zhang T, Li N, Chen H, Li H, Wu H. Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy. Sci Rep 2016;6:36234. [PMID: 27830756 DOI: 10.1038/srep36234] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
74 Allegra A, Di Gioacchino M, Tonacci A, Musolino C, Gangemi S. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications. Int J Mol Sci 2020;21:E4782. [PMID: 32640747 DOI: 10.3390/ijms21134782] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 31.0] [Reference Citation Analysis]
75 Schönrich G, Raftery MJ. The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance. Front Cell Infect Microbiol 2019;9:207. [PMID: 31263684 DOI: 10.3389/fcimb.2019.00207] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 36.5] [Reference Citation Analysis]
76 Jiang H, Shen SM, Yin J, Zhang PP, Shi Y. Influenza virus non‑structural protein 1 inhibits the production of interferon β of alveolar epithelial cells upon the infection of influenza A H1N1. Mol Med Rep 2017;16:4553-60. [PMID: 28765967 DOI: 10.3892/mmr.2017.7138] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Sa Ribero M, Jouvenet N, Dreux M, Nisole S. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog 2020;16:e1008737. [PMID: 32726355 DOI: 10.1371/journal.ppat.1008737] [Cited by in Crossref: 140] [Cited by in F6Publishing: 106] [Article Influence: 140.0] [Reference Citation Analysis]
78 Piganelli JD, Mamula MJ, James EA. The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes. Front Endocrinol (Lausanne) 2020;11:624590. [PMID: 33679609 DOI: 10.3389/fendo.2020.624590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Adas G, Cukurova Z, Yasar KK, Yilmaz R, Isiksacan N, Kasapoglu P, Yesilbag Z, Koyuncu ID, Karaoz E. The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial. Cell Transplant 2021;30:9636897211024942. [PMID: 34180719 DOI: 10.1177/09636897211024942] [Reference Citation Analysis]
80 Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol 2020;85:106688. [PMID: 32544867 DOI: 10.1016/j.intimp.2020.106688] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 35.0] [Reference Citation Analysis]
81 Nenasheva VV, Nikitenko NA, Stepanenko EA, Makarova IV, Andreeva LE, Kovaleva GV, Lysenko AA, Tukhvatulin AI, Logunov DY, Tarantul VZ. Human TRIM14 protects transgenic mice from influenza A viral infection without activation of other innate immunity pathways. Genes Immun 2021;22:56-63. [PMID: 33864033 DOI: 10.1038/s41435-021-00128-6] [Reference Citation Analysis]
82 Sender V, Hentrich K, Henriques-Normark B. Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae. Front Cell Infect Microbiol 2021;11:643326. [PMID: 33828999 DOI: 10.3389/fcimb.2021.643326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Gorgoglione B, Taylor NG, Holland JW, Feist SW, Secombes CJ. Immune response modulation upon sequential heterogeneous co-infection with Tetracapsuloides bryosalmonae and VHSV in brown trout (Salmo trutta). Fish & Shellfish Immunology 2019;88:375-90. [DOI: 10.1016/j.fsi.2019.02.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
84 Maini MK, Gehring AJ. The role of innate immunity in the immunopathology and treatment of HBV infection. J Hepatol. 2016;64:S60-S70. [PMID: 27084038 DOI: 10.1016/j.jhep.2016.01.028] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 23.0] [Reference Citation Analysis]
85 Alosaimi B, Hamed ME, Naeem A, Alsharef AA, AlQahtani SY, AlDosari KM, Alamri AA, Al-Eisa K, Khojah T, Assiri AM, Enani MA. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Cytokine 2020;126:154895. [PMID: 31706200 DOI: 10.1016/j.cyto.2019.154895] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 25.0] [Reference Citation Analysis]
86 Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, von Wissmann B, Reynolds A, McMenamin J, Gunson RN, Murcia PR. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A 2019:201911083. [PMID: 31843887 DOI: 10.1073/pnas.1911083116] [Cited by in Crossref: 115] [Cited by in F6Publishing: 82] [Article Influence: 57.5] [Reference Citation Analysis]
87 Castelli V, Cimini A, Ferri C. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in". Front Immunol. 2020;11:2132. [PMID: 32983172 DOI: 10.3389/fimmu.2020.02132] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 34.0] [Reference Citation Analysis]
88 Karimi Y, Giles EC, Vahedi F, Chew MV, Nham T, Loukov D, Lee AJ, Bowdish DM, Ashkar AA. IFN-β signalling regulates RAW 264.7 macrophage activation, cytokine production, and killing activity. Innate Immun 2020;26:172-82. [PMID: 31615311 DOI: 10.1177/1753425919878839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Abdin SM, Elgendy SM, Alyammahi SK, Alhamad DW, Omar HA. Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sci 2020;257:118054. [PMID: 32663575 DOI: 10.1016/j.lfs.2020.118054] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 28.0] [Reference Citation Analysis]
90 Maier BB, Hladik A, Lakovits K, Korosec A, Martins R, Kral JB, Mesteri I, Strobl B, Müller M, Kalinke U, Merad M, Knapp S. Type I interferon promotes alveolar epithelial type II cell survival during pulmonary Streptococcus pneumoniae infection and sterile lung injury in mice. Eur J Immunol 2016;46:2175-86. [PMID: 27312374 DOI: 10.1002/eji.201546201] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
91 Klinkhammer J, Schnepf D, Ye L, Schwaderlapp M, Gad HH, Hartmann R, Garcin D, Mahlakõiv T, Staeheli P. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife 2018;7:e33354. [PMID: 29651984 DOI: 10.7554/eLife.33354] [Cited by in Crossref: 109] [Cited by in F6Publishing: 73] [Article Influence: 36.3] [Reference Citation Analysis]
92 Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, Yousif AS, Bals J, Hauser BM, Feldman J, Muus C, Wadsworth MH 2nd, Kazer SW, Hughes TK, Doran B, Gatter GJ, Vukovic M, Taliaferro F, Mead BE, Guo Z, Wang JP, Gras D, Plaisant M, Ansari M, Angelidis I, Adler H, Sucre JMS, Taylor CJ, Lin B, Waghray A, Mitsialis V, Dwyer DF, Buchheit KM, Boyce JA, Barrett NA, Laidlaw TM, Carroll SL, Colonna L, Tkachev V, Peterson CW, Yu A, Zheng HB, Gideon HP, Winchell CG, Lin PL, Bingle CD, Snapper SB, Kropski JA, Theis FJ, Schiller HB, Zaragosi LE, Barbry P, Leslie A, Kiem HP, Flynn JL, Fortune SM, Berger B, Finberg RW, Kean LS, Garber M, Schmidt AG, Lingwood D, Shalek AK, Ordovas-Montanes J; HCA Lung Biological Network. Electronic address: lung-network@humancellatlas.org., HCA Lung Biological Network. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell 2020;181:1016-1035.e19. [PMID: 32413319 DOI: 10.1016/j.cell.2020.04.035] [Cited by in Crossref: 964] [Cited by in F6Publishing: 830] [Article Influence: 964.0] [Reference Citation Analysis]
93 [DOI: 10.1101/851543] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Moura LM, Ferreira VLR, Loureiro RM, de Paiva JPQ, Rosa-Ribeiro R, Amaro E Jr, Soares MBP, Machado BS. The Neurobiology of Zika Virus: New Models, New Challenges. Front Neurosci 2021;15:654078. [PMID: 33897363 DOI: 10.3389/fnins.2021.654078] [Reference Citation Analysis]
95 Channappanavar R, Fehr AR, Zheng J, Wohlford-Lenane C, Abrahante JE, Mack M, Sompallae R, McCray PB Jr, Meyerholz DK, Perlman S. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019;129:3625-3639. [PMID: 31355779 DOI: 10.1172/jci126363] [Cited by in Crossref: 250] [Cited by in F6Publishing: 175] [Article Influence: 125.0] [Reference Citation Analysis]